CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-08 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 121,635 | ||
| 2021-11-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +1,000 | $1.68 | $2K | 595,779 |
| 2021-11-05 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.50 | $22K | 594,779 |
| 2021-11-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 122,635 | ||
| 2021-11-01 | Welgus Howard G. Director | Exercise or conversion | +2,500 | $0.58 | $1K | 184,396 |
| 2021-11-01 | Welgus Howard G. Director | Sale | −2,500 | $21.81 | $55K | 181,896 |
| 2021-11-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 20,106 | ||
| 2021-10-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +2,500 | $1.68 | $4K | 597,279 |
| 2021-10-05 | Watanabe Todd Franklin President and CEO | Sale | −2,500 | $24.92 | $62K | 594,779 |
| 2021-10-05 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 123,635 | ||
| 2021-10-01 | Welgus Howard G. Director | Exercise or conversion | +2,500 | $0.58 | $1K | 184,396 |
| 2021-10-01 | Welgus Howard G. Director | Sale | −2,500 | $23.87 | $60K | 181,896 |
| 2021-10-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −2,500 | 22,606 | ||
| 2021-10-01 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +1,500 | $1.68 | $3K | 596,279 |
| 2021-10-01 | Watanabe Todd Franklin President and CEO | Sale | −1,500 | $25.01 | $38K | 594,779 |
| 2021-10-01 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 126,135 | ||
| 2021-09-07 | Watanabe Todd Franklin President and CEO | Exercise or conversion | +1,000 | $1.68 | $2K | 595,779 |
| 2021-09-07 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.14 | $21K | 594,779 |
| 2021-09-07 | Watanabe Todd Franklin President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 127,635 | ||
| 2021-09-02 | Leonard Keith R Director | Grant or award · Stock Option (Right to Buy) | +32,907 | 32,907 |
Page 34 of 35 · 689 trades